{"id":"https://openalex.org/W7220416144","doi":"https://doi.org/10.3389/fgene.2026.1876053","title":"Prevalence of migalastat-amenable variants in patients with Fabry disease from Brazil, Argentina, and Colombia: an observational study","display_name":"Prevalence of migalastat-amenable variants in patients with Fabry disease from Brazil, Argentina, and Colombia: an observational study","publication_year":2026,"publication_date":"2026-10-05","ids":{"openalex":"https://openalex.org/W7220416144","doi":"https://doi.org/10.3389/fgene.2026.1876053","pmid":"https://pubmed.ncbi.nlm.nih.gov/42898486","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13678124"},"language":"en","primary_location":{"id":"doi:10.3389/fgene.2026.1876053","doi":"https://doi.org/10.3389/fgene.2026.1876053","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fgene.2026.1876053","pdf_url":"https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876053/pdf","source":{"id":"https://openalex.org/S2597340651","display_name":"Frontiers in Genetics","issn_l":"1664-8021","issn":["1664-8021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Genetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876053/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081997204","display_name":"Juan Manuel Politei","orcid":"https://orcid.org/0000-0003-3882-3136","observed_orcids":["https://orcid.org/0000-0003-3882-3136"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Juan Manuel Politei","raw_affiliation_strings":["Neurology Department, SPINE Fundation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Department, SPINE Fundation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054797513","display_name":"Ana Mar\u00eda Zarante Baham\u00f3n","orcid":"https://orcid.org/0000-0002-2244-0838","observed_orcids":["https://orcid.org/0000-0002-2244-0838"]},"institutions":[{"id":"https://openalex.org/I4210153247","display_name":"Hospital Universitario San Ignacio","ror":"https://ror.org/052d0td05","country_code":"CO","type":"healthcare","lineage":["https://openalex.org/I4210153247"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Ana Mar\u00eda Zarante Baham\u00f3n","raw_affiliation_strings":["San Ignacio University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Ignacio University Hospital","institution_ids":["https://openalex.org/I4210153247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100760506","display_name":"Ana Mar\u00eda Martins","orcid":"https://orcid.org/0000-0003-2239-0882","observed_orcids":["https://orcid.org/0000-0003-2239-0882"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ana Maria Martins","raw_affiliation_strings":["Federal University of S\u00e3o Paulo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Federal University of S\u00e3o Paulo","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157639698","display_name":"Afr\u00e2nio Souza De Melo","orcid":"https://orcid.org/0009-0005-6657-6306","observed_orcids":["https://orcid.org/0009-0005-6657-6306"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Afr\u00e2nio Souza De Melo","raw_affiliation_strings":["Federal University of S\u00e3o Paulo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Federal University of S\u00e3o Paulo","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041084408","display_name":"Marcelo Horacio de Sa Pereira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40034438","display_name":"Universidade do Estado do Rio de Janeiro","ror":"https://ror.org/0198v2949","country_code":"BR","type":"education","lineage":["https://openalex.org/I40034438"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Marcelo Horacio de Sa Pereira","raw_affiliation_strings":["State University of Rio de Janeiro"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State University of Rio de Janeiro","institution_ids":["https://openalex.org/I40034438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004625309","display_name":"Andr\u00e9ia Assis Loures-Vale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1306559669","display_name":"Amicus Therapeutics (United Kingdom)","ror":"https://ror.org/05n451y37","country_code":"GB","type":"company","lineage":["https://openalex.org/I1306559669","https://openalex.org/I4210134439"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andr\u00e9ia Loures-Vale","raw_affiliation_strings":["Amicus Therapeutics UK Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics UK Ltd","institution_ids":["https://openalex.org/I1306559669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083671011","display_name":"Biliana O. Veleva-Rotse","orcid":"https://orcid.org/0000-0002-7783-0112","observed_orcids":["https://orcid.org/0000-0002-7783-0112"]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Biliana O. Veleva-Rotse","raw_affiliation_strings":["BioMarin Pharmaceutical Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMarin Pharmaceutical Inc","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081664185","display_name":"Eva Krusinska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134439","display_name":"Amicus Therapeutics (United States)","ror":"https://ror.org/0328xw886","country_code":"US","type":"company","lineage":["https://openalex.org/I4210134439"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eva Krusinska","raw_affiliation_strings":["Amicus Therapeutics Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amicus Therapeutics Inc","institution_ids":["https://openalex.org/I4210134439"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015849918","display_name":"Valerie Lengoc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097968","display_name":"BioMarin (United Kingdom)","ror":"https://ror.org/0103q2z38","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210097968","https://openalex.org/I91786662"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Valerie Lengoc","raw_affiliation_strings":["BioMarin UK Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioMarin UK Ltd","institution_ids":["https://openalex.org/I4210097968"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5081997204"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75158684,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1876053","last_page":"1876053"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fabry-disease","display_name":"Fabry disease","score":1.0},{"id":"https://openalex.org/keywords/migalastat","display_name":"migalastat","score":0.9660000205039978},{"id":"https://openalex.org/keywords/alpha-galactosidase-a","display_name":"alpha-galactosidase A","score":0.8840000033378601},{"id":"https://openalex.org/keywords/pharmacological-chaperone-therapy","display_name":"pharmacological chaperone therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/variant-prevalence","display_name":"variant prevalence","score":0.75},{"id":"https://openalex.org/keywords/lysosomal-storage-disorders","display_name":"lysosomal storage disease","score":0.7789999842643738},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cardiac-involvement","display_name":"cardiac involvement","score":0.9430000185966492},{"id":"https://openalex.org/keywords/brazil","display_name":"Brazil","score":0.49900001287460327},{"id":"https://openalex.org/keywords/argentina","display_name":"Argentina","score":0.9990000128746033},{"id":"https://openalex.org/keywords/colombia","display_name":"Colombia","score":1.0}],"concepts":[{"id":"https://openalex.org/C2777404818","wikidata":"https://www.wikidata.org/wiki/Q615645","display_name":"Fabry disease","level":3,"score":0.9556999802589417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7150999903678894},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5996999740600586},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.5309000015258789},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5267000198364258},{"id":"https://openalex.org/C2777687718","wikidata":"https://www.wikidata.org/wiki/Q410539","display_name":"Globotriaosylceramide","level":4,"score":0.4973999857902527},{"id":"https://openalex.org/C2779969927","wikidata":"https://www.wikidata.org/wiki/Q916766","display_name":"Enzyme replacement therapy","level":3,"score":0.4832000136375427},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.47429999709129333},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4438000023365021},{"id":"https://openalex.org/C27502469","wikidata":"https://www.wikidata.org/wiki/Q906343","display_name":"Dysfunctional family","level":2,"score":0.42879998683929443},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4244000017642975},{"id":"https://openalex.org/C2993153387","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic diagnosis","level":3,"score":0.42239999771118164},{"id":"https://openalex.org/C2776788019","wikidata":"https://www.wikidata.org/wiki/Q83170235","display_name":"Alpha-galactosidase","level":4,"score":0.4122999906539917},{"id":"https://openalex.org/C2778264360","wikidata":"https://www.wikidata.org/wiki/Q675010","display_name":"Lysosomal storage disease","level":3,"score":0.33959999680519104},{"id":"https://openalex.org/C2781179581","wikidata":"https://www.wikidata.org/wiki/Q2857712","display_name":"Family history","level":2,"score":0.32760000228881836},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.2996000051498413},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.28850001096725464},{"id":"https://openalex.org/C2993807623","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genetic data","level":3,"score":0.2799000144004822},{"id":"https://openalex.org/C2779701055","wikidata":"https://www.wikidata.org/wiki/Q929833","display_name":"Rare disease","level":3,"score":0.2793999910354614},{"id":"https://openalex.org/C2777767895","wikidata":"https://www.wikidata.org/wiki/Q4691924","display_name":"Age of onset","level":3,"score":0.27399998903274536},{"id":"https://openalex.org/C2780664029","wikidata":"https://www.wikidata.org/wiki/Q5282120","display_name":"Disease burden","level":3,"score":0.2736999988555908},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.2736999988555908},{"id":"https://openalex.org/C2778908642","wikidata":"https://www.wikidata.org/wiki/Q200779","display_name":"Genetic disorder","level":3,"score":0.2646999955177307},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.25209999084472656}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fgene.2026.1876053","doi":"https://doi.org/10.3389/fgene.2026.1876053","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fgene.2026.1876053","pdf_url":"https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876053/pdf","source":{"id":"https://openalex.org/S2597340651","display_name":"Frontiers in Genetics","issn_l":"1664-8021","issn":["1664-8021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Genetics","raw_type":"journal-article"},{"id":"pmid:42898486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42898486","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in genetics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13678124","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13678124/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Genet","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:8d34fa8f0db34af4861f622aaa9edcd0","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8d34fa8f0db34af4861f622aaa9edcd0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Genetics, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fgene.2026.1876053","doi":"https://doi.org/10.3389/fgene.2026.1876053","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fgene.2026.1876053","pdf_url":"https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2026.1876053/pdf","source":{"id":"https://openalex.org/S2597340651","display_name":"Frontiers in Genetics","issn_l":"1664-8021","issn":["1664-8021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Genetics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220416144.pdf","grobid_xml":"https://content.openalex.org/works/W7220416144.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W2126269101","https://openalex.org/W2137567062","https://openalex.org/W2150885355","https://openalex.org/W2165008949","https://openalex.org/W2523056550","https://openalex.org/W2566128997","https://openalex.org/W2789753965","https://openalex.org/W2967605415","https://openalex.org/W3022047066","https://openalex.org/W3138924345","https://openalex.org/W4200044565","https://openalex.org/W4211146209","https://openalex.org/W4213076590","https://openalex.org/W4214521169","https://openalex.org/W4220866122","https://openalex.org/W4296919006","https://openalex.org/W4319293926","https://openalex.org/W4379422209","https://openalex.org/W4386408783","https://openalex.org/W4387847834","https://openalex.org/W4391923216","https://openalex.org/W4409482573"],"related_works":["https://openalex.org/W4391923216","https://openalex.org/W2970852975","https://openalex.org/W4317933329","https://openalex.org/W7160828050","https://openalex.org/W6943920221","https://openalex.org/W7127565927","https://openalex.org/W4391379708","https://openalex.org/W2938214373","https://openalex.org/W4409281592","https://openalex.org/W2911457522"],"abstract_inverted_index":{"Introduction":[0],"Fabry":[1,59,92,116,234,245],"disease":[2,60,93,117,246],"is":[3,25],"a":[4,89],"progressive,":[5],"X-linked":[6],"lysosomal":[7],"disorder":[8],"caused":[9],"by":[10,158,238],"GLA":[11,37,138],"variants":[12,54,139,156,192],"that":[13],"result":[14],"in":[15,63,118,143,147,152,166,171,199,212],"dysfunctional":[16],"\u03b1-galactosidase":[17],"A":[18,100],"(\u03b1-Gal":[19],"A)":[20],"enzyme.":[21],"One":[22],"treatment":[23,32],"option":[24],"migalastat,":[26],"an":[27],"oral":[28],"small-molecule":[29],"pharmacological":[30],"chaperone":[31],"for":[33,58,105,111,188,219],"patients":[34,142],"with":[35,88,115,160,190],"migalastat-amenable":[36,53,137,155,191],"variants.":[38,175],"Methods":[39],"In":[40,217],"this":[41],"retrospective":[42],"study,":[43],"medical":[44],"records":[45,80],"were":[46,74,103,109,209,222],"used":[47],"to":[48,226],"determine":[49],"the":[50,164,172,181],"prevalence":[51],"of":[52,81,85,91,132,233],"among":[55,163],"individuals":[56,113,189],"managed":[57],"at":[61,180],"centers":[62],"Brazil,":[64,144,167,200],"Argentina,":[65,148,168,201],"and":[66,71,127,149,169,196,202,214,230,243,248],"Colombia":[67,128,170],"(primary":[68],"endpoint).":[69],"Demographic":[70],"clinical":[72,207],"characteristics":[73,208],"explored":[75],"using":[76],"available":[77,210],"data.":[78],"Medical":[79],"males":[82],"or":[83],"females":[84],"any":[86],"age":[87,177],"diagnosis":[90],"(based":[94],"on":[95,206],"genetic":[96],"testing":[97],"and/or":[98],"\u03b1-Gal":[99],"enzymatic":[101],"activity)":[102],"eligible":[104],"inclusion.":[106],"Results":[107],"Data":[108,205],"collected":[110],"1,196":[112],"diagnosed":[114],"Brazil":[119],"(n":[120,124,129],"=":[121,125,130],"1,000),":[122],"Argentina":[123,213],"122),":[126],"74);":[131],"these,":[133],"720":[134],"(60.2%)":[135],"had":[136],"(650":[140],"[65.0%]":[141],"32":[145],"[26.2%]":[146],"38":[150],"[51.4%]":[151],"Colombia).":[153],"The":[154],"differed":[157],"country":[159],"little":[161],"overlap":[162],"cohorts":[165],"most":[173],"common":[174],"Median":[176],"(in":[178],"years)":[179],"study":[182],"reference":[183],"date":[184],"(July":[185],"1,":[186],"2021)":[187],"was":[193],"45.6,":[194],"44.1,":[195],"21.8":[197],"years":[198],"Colombia,":[203],"respectively.":[204],"only":[211],"Colombia.":[215],"Discussion":[216],"those":[218],"whom":[220],"data":[221],"available,":[223],"there":[224],"appeared":[225],"be":[227],"both":[228],"objective":[229],"subjective":[231],"manifestations":[232],"disease,":[235],"as":[236],"evidenced":[237],"renal":[239],"impairment,":[240],"cardiac":[241],"involvement,":[242],"classic":[244],"signs":[247],"symptoms.":[249]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-06T00:00:00"}